Avacta : Results for the Year Ended 31 December 2023
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATIONS NO. 596/2014 AS IT FORMS...
Stay updated with breaking news from Avacta Diagnostics Division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATIONS NO. 596/2014 AS IT FORMS...
Avacta appoints new Chief Executive Officer Christina Coughlin, MD PhD Clinical proof-of-concept demonstrated for Avacta's lead programme AVA6000 and proof-of-mechanism for the...
A period of continued significant progress Avacta Group plc , a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, is pleased to... | April 25, 2023
Investegate announcements from Avacta Group PLC, Issue of Equity and Total Voting Rights
Investegate announcements from Avacta Group PLC, Issue of Equity and Total Voting Rights